The antiphospholipid syndrome (APS) is an autoimmune, multisystemic disorder associated with recurrent thrombosis (arterial and/or venous) and pregnancy loss, among other clinical manifestations. The ...

Some people with lupus will develop a condition called Antiphospholipid Syndrome (APS). APS can lead to blood clots, and for pregnant women with lupus, pregnancy complications. We talk with Dr. Jane ...

Arterial thrombosis, venous thrombosis and morbidity during pregnancy, or a combination of these events, are clinical outcomes associated with antiphospholipid antibodies produced by patients with ...

The gut microbiomes of patients with antiphospholipid syndrome show higher levels of phospholipid-producing bacteria, and this findings point to microbes being a trigger for this life-threatening ...

The presence of antiphospholipid antibodies has been shown to be related to an increased risk of thrombotic events. In patients with definite antiphospholipid syndrome (APS), that is, those who have ...

Neutrophils are an important type of white blood cell that help your immune system fight infections. One of the many ways neutrophils help is by capturing germs in sticky, spider web-like structures ...

The IMprove Pregnancy in APS with Certolizumab Therapy (IMPACT) clinical trial, supported by the Lupus Foundation of America through a three-year grant, found that certolizumab pegol, a medication ...

Antiphospholipid syndrome, also known as APS, is an autoimmune disease that sits at the intersection of inflammation and blood clotting. Antiphospholipid syndrome is best known for increasing the risk ...

APS classification criteria were last updated in 2006 and did not incorporate the wider range of manifestations of APS, including heart valve and kidney disease. The ACR and the European Alliance of ...

Asherson’s syndrome, also known as catastrophic antiphospholipid syndrome (CAPS), is an extremely rare autoimmune condition. It is defined by the fast progression of blood clots impacting many organ ...

Presence of anti-PS/PT IgG or IgM antibodies indicates a high risk category of patients Antiphospholipid antibodies are not directed against phospholipids, but rather to phospholipid-protein complexes ...